Prostate-specific antigen adjusted for the transition zone volume as a second screening test: A prospective study of 248 cases

International Journal of Urology

Volumn 13, Issue 7, 2006, Pages 910-914

  Kang, Seok Ho ^a   Bae, Jae Hyun ^a   Park, Hong Seok ^a   Yoon, Duck Ki ^a   Moon, Du Geon ^a   Kim, Je Jong ^a   Cheon, Jun ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University Ansan Hospital   (South Korea)

Author keywords

Prostate cancer; PSA; PSATZ; Screening test

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CALCULATION; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITY; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MICTURITION DISORDER; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE SPECIFIC ANTIGEN ADJUSTED FOR THE TRANSITION ZONE VOLUME; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; TUMOR BIOPSY;

AGED; BIOPSY; DIAGNOSIS, DIFFERENTIAL; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 33745921755     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01439.x     Document Type: Article

References (14)

1. Mettlin CJ, Littrup PJ, Kane RA et al. Relative sensitivity and specificity of serum prostate specific antigen (PSA) level compared with age-referenced PSA, PSA density and PSA change. Cancer 1994; 74: 1615-20.
2. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res. 1991; 51: 222-6.
3. Kalish J, Cooner WH, Graham SD Jr. Serum PSA adjusted for Volume of transition zone (PSATZ) is more accurate than PSA adjusted for total gland Volume (PSAD) in detecting adenocarcinoma of the prostate. Urology 1994; 43: 601-6.
4. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J. Urol. 1992; 147: 817-21.
5. Weber JP, Oesterling JE, Peters CA, Partin AW, Chan DW, Walsh PC. The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J. Urol. 1989; 141: 987-92.
6. Babaian RJ. Extended field prostate biopsy enhances cancer detection. Urology 2000; 55: 453-6.
7. Terris MK. Extended field prostate biopsies: too much of a good thing? Urology 2000; 55: 457-60.
8. Catalona WJ, Smith DS, Wolfert RL et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA 1995; 274: 1214-20.
9. Luderer AA, Chen YT, Soriano TF et al. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 1995; 46: 187-94.
10. Catalona WJ, Beiser JA, Smith DS. Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J. Urol. 1997; 158: 2162-7.
11. Lin DW, Gold MH, Ransom S, Ellis WJ, Brawer MK. Transition zone prostate specific antigen density: lack of use in prediction of prostatic carcinoma. J. Urol. 1998; 160: 77-82.
12. Zlotta AR, Djavan B, Marberger M, Schulman CC. Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction. J. Urol. 1997; 157: 1315-21.
13. Moon DG, Cheon J, Kim JJ, Yoon DK, Koh SK. Prostate-specific antigen adjusted for the transition zone Volume versus free-to-total prostate-specific antigen ratio in predicting prostate cancer. Int. J. Urol. 1999; 6: 455-62.
14. Moon DG, Yu JW, Lee JG, Kim JJ, Koh SK, Cheon J. The influence of prostate Volume on the prostate-specific antigen (PSA) level adjusted for the transition zone volume and free-to-total PSA ratio: a prospective study. BJU Int. 2000; 86: 670-4.